Hiromi Rakugi Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2021	The Combination of High Levels of Adiponectin and Insulin Resistance Are Affected by Aging in Non-Obese Old Peoples.
6/2014	Anti-inflammatory effects of hepatocyte growth factor on the vicious cycle of macrophages and adipocytes.
1/2013	Improvement of metabolic syndrome by irbesartan via the PPARγ/HGF pathway in apolipoprotein E knockout mice.
1/2013	Adiponectin single nucleotide polymorphism is a genetic risk factor for stroke through high pulse wave pressure: a cohort study.
3/2010	Association of gene polymorphism of the fat-mass and obesity-associated gene with insulin resistance in Japanese.
6/2005	Association of hypoadiponectinemia with smoking habit in men.
6/2004	Hypoadiponectinemia is an independent risk factor for hypertension.
6/2004	[Hypertension].
4/2004	Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.
10/2002	[Role of angiotensin in the metabolic syndrome and cardiovascular complications].

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiromi Rakugi Research Topics

Disease

78	Hypertension (High Blood Pressure) 05/2022 - 06/2002
32	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 12/2004
30	Insulin Resistance 01/2021 - 01/2002
29	Chronic Renal Insufficiency 04/2022 - 12/2006
29	Essential Hypertension 01/2022 - 07/2003
22	Inflammation (Inflammations) 01/2021 - 10/2006
20	Fibrosis (Cirrhosis) 01/2021 - 07/2007
20	Atherosclerosis 01/2021 - 04/2002
18	Type 2 Diabetes Mellitus (MODY) 11/2022 - 11/2002
18	Stroke (Strokes) 05/2021 - 07/2009
18	Proteinuria 06/2015 - 07/2004
17	Diabetes Mellitus 11/2022 - 11/2009
13	Obesity 01/2021 - 09/2003
11	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 04/2002
11	Dementia (Dementias) 01/2020 - 07/2009
11	Alzheimer Disease (Alzheimer's Disease) 01/2020 - 07/2009
10	Neoplasms (Cancer) 10/2021 - 10/2012
10	Body Weight (Weight, Body) 01/2020 - 06/2005
8	Cognitive Dysfunction 04/2022 - 07/2009
8	Frailty 01/2021 - 01/2018
8	Vascular Remodeling 12/2020 - 02/2004
7	Dyslipidemias (Dyslipidemia) 04/2021 - 05/2011
7	Hyperaldosteronism (Conn Syndrome) 01/2021 - 01/2012
7	Osteoporosis 03/2019 - 05/2009
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 04/2004
7	Vascular Calcification 01/2019 - 05/2009
7	Kidney Diseases (Kidney Disease) 01/2016 - 01/2006
7	Chronic Kidney Failure (Chronic Renal Failure) 01/2016 - 01/2010
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 04/2010
6	Albuminuria 01/2021 - 04/2010
6	Ulcer 01/2020 - 12/2011
6	Peripheral Arterial Disease 08/2018 - 08/2005
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 04/2013 - 12/2004
5	Sarcopenia 11/2022 - 01/2018
5	COVID-19 09/2022 - 11/2020
5	Heart Failure 04/2022 - 04/2006
5	Fatty Liver 01/2020 - 01/2009
5	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2002
5	Hypertrophy 04/2015 - 04/2006
5	Hyperuricemia 01/2013 - 07/2005
4	Muscle Weakness 01/2021 - 10/2018

Drug/Important Bio-Agent (IBA)

29	Antihypertensive Agents (Antihypertensives)IBA 04/2022 - 06/2002
20	Angiotensin IIIBA 11/2021 - 06/2004
16	Insulin (Novolin)FDA Link 11/2022 - 01/2002
16	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2007
16	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2020 - 02/2004
13	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2009
13	CreatinineIBA 10/2019 - 06/2005
13	Angiotensin Receptor AntagonistsIBA 01/2018 - 04/2005
11	Pharmaceutical PreparationsIBA 10/2021 - 04/2005
10	SaltsIBA 05/2022 - 07/2003
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2009
10	olmesartanIBA 01/2022 - 02/2004
10	Peptides (Polypeptides)IBA 01/2021 - 06/2011
10	AdiponectinIBA 01/2021 - 09/2003
10	DiureticsIBA 10/2020 - 06/2005
10	benidipineIBA 01/2020 - 09/2007
9	AngiotensinsIBA 11/2020 - 01/2002
9	Amlodipine (Norvasc)FDA LinkGeneric 01/2018 - 01/2006
8	esaxerenoneIBA 01/2022 - 01/2019
8	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2022 - 01/2019
8	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2020 - 04/2004
8	LipidsIBA 01/2019 - 09/2009
8	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2012 - 06/2005
7	Uric Acid (Urate)IBA 01/2021 - 07/2005
7	MagnesiumIBA 01/2019 - 05/2009
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2019 - 01/2006
7	CalciumIBA 01/2015 - 04/2005
6	VaccinesIBA 09/2022 - 01/2013
6	LigandsIBA 01/2021 - 06/2013
6	ThiazidesIBA 01/2020 - 04/2012
6	Valsartan (Vals)FDA Link 01/2019 - 07/2004
6	ReninIBA 01/2019 - 01/2002
6	azilsartanIBA 01/2018 - 05/2012
6	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2018 - 04/2005
6	Indicators and Reagents (Reagents)IBA 01/2017 - 10/2011
6	Parathyroid Hormone (Parathormone)IBA 11/2016 - 06/2012
6	Fibroblast Growth Factor-23IBA 01/2016 - 04/2009
6	MineralsIBA 01/2016 - 05/2009
6	Losartan (Cozaar)FDA LinkGeneric 05/2015 - 07/2004
6	Vitamin D FDA LinkGeneric 01/2015 - 08/2009
6	Amyloid beta-PeptidesIBA 01/2012 - 07/2009
5	angiotensin I (1-7)IBA 11/2020 - 04/2009
5	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2018 - 01/2014
5	Phosphates (Orthophosphate)IBA 10/2015 - 05/2009
5	Type 1 Angiotensin ReceptorIBA 08/2015 - 07/2004
5	candesartanIBA 06/2014 - 12/2007
5	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2011 - 07/2005
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2010
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 11/2017
4	Neutralizing AntibodiesIBA 10/2021 - 12/2010
4	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021 - 07/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 09/2009
4	Angiotensin-Converting Enzyme 2IBA 01/2021 - 01/2013
4	Messenger RNA (mRNA)IBA 01/2021 - 07/2007

Therapy/Procedure

48	Therapeutics 11/2022 - 06/2002
9	Renal Dialysis (Hemodialysis) 12/2018 - 07/2009
5	Activities of Daily Living (ADL) 04/2022 - 07/2009
5	Adrenalectomy 01/2021 - 10/2018
4	Glycemic Control 11/2022 - 11/2019